FR2423217A2 - Procede de vaccination contre la myxomatose - Google Patents

Procede de vaccination contre la myxomatose

Info

Publication number
FR2423217A2
FR2423217A2 FR7807556A FR7807556A FR2423217A2 FR 2423217 A2 FR2423217 A2 FR 2423217A2 FR 7807556 A FR7807556 A FR 7807556A FR 7807556 A FR7807556 A FR 7807556A FR 2423217 A2 FR2423217 A2 FR 2423217A2
Authority
FR
France
Prior art keywords
vaccine
aerosol
administration
myxomatosis
inhalation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7807556A
Other languages
English (en)
Other versions
FR2423217B2 (fr
Inventor
Pierre Saurat
Yves Gilbert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Priority to FR7807556A priority Critical patent/FR2423217A2/fr
Publication of FR2423217A2 publication Critical patent/FR2423217A2/fr
Application granted granted Critical
Publication of FR2423217B2 publication Critical patent/FR2423217B2/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24211—Parapoxvirus, e.g. Orf virus
    • C12N2710/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne un procédé de vaccination pour la protection de lapins contre la myxomatose. Ce procédé consiste à administrer aux animaux par voie respiratoire sous forme d'aérosol ou d'instillation nasale, un vaccin du type de celui visé dans la demande principale. Le procédé conforme à l'invention simplifie considérablement sur le plan pratique les opérations de vaccination et permet de vacciner simultanément et très rapidement un grand nombre de lapins sans avoir à les capturer.
FR7807556A 1978-03-10 1978-03-10 Procede de vaccination contre la myxomatose Granted FR2423217A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7807556A FR2423217A2 (fr) 1978-03-10 1978-03-10 Procede de vaccination contre la myxomatose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7807556A FR2423217A2 (fr) 1978-03-10 1978-03-10 Procede de vaccination contre la myxomatose

Publications (2)

Publication Number Publication Date
FR2423217A2 true FR2423217A2 (fr) 1979-11-16
FR2423217B2 FR2423217B2 (fr) 1981-06-26

Family

ID=9205856

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7807556A Granted FR2423217A2 (fr) 1978-03-10 1978-03-10 Procede de vaccination contre la myxomatose

Country Status (1)

Country Link
FR (1) FR2423217A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593397A1 (fr) * 1986-01-22 1987-07-31 Ass Nale Chasseurs Lapin Procede de vaccination de lapins sauvages (oryctolagus cuniculi) contre la myxomatose a l'aide d'insectes vecteurs porteurs d'un virus vaccin non pathogene
WO1995011664A1 (fr) * 1993-10-26 1995-05-04 Transgene S.A. Procede de preparation d'un aerosol viral

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7414M (fr) * 1968-04-22 1969-11-12
FR2103608A1 (fr) * 1970-08-29 1972-04-14 Philips Nv

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7414M (fr) * 1968-04-22 1969-11-12
FR2103608A1 (fr) * 1970-08-29 1972-04-14 Philips Nv

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593397A1 (fr) * 1986-01-22 1987-07-31 Ass Nale Chasseurs Lapin Procede de vaccination de lapins sauvages (oryctolagus cuniculi) contre la myxomatose a l'aide d'insectes vecteurs porteurs d'un virus vaccin non pathogene
WO1995011664A1 (fr) * 1993-10-26 1995-05-04 Transgene S.A. Procede de preparation d'un aerosol viral
FR2711523A1 (fr) * 1993-10-26 1995-05-05 Transgene Sa Procédé de préparation d'un aérosol viral.
US5952220A (en) * 1993-10-26 1999-09-14 Transgene S.A. Method for preparing a viral aerosol
US6582694B2 (en) 1993-10-26 2003-06-24 Transgene S.A. Method for preparing a viral aerosol

Also Published As

Publication number Publication date
FR2423217B2 (fr) 1981-06-26

Similar Documents

Publication Publication Date Title
TW246641B (fr)
DK32987A (da) Fremgangsmaade og system til liposominhalering
ES2084360T3 (es) Formulaciones de aerosoles exentas de clorofluorocarbonos.
GB1473925A (en) Surgical face mask
IL56405A0 (en) Novel substituted n-pehnyl-n'-(2-chloro-6-fluoro-benzoyl)-ureas, their preparation and their use as insecticides
IE780811L (en) Vaccine against newcastle disease
BE853810A (fr) Procede de preparation d'un vaccin contre le virus, de la rhinopneumonie equine et vaccin ainsi obtenu
PT88524A (pt) Process of preparation of a vaccine for the protection of birdsagainst contagions by mycoplasma and the preparation of a pure culture of the same
FR2565825B1 (fr) Vaccin contre les maladies dues a des microorganismes tels que des mycoplasmes, sa preparation et membranes de microorganismes en tant que principe actif
FR2423217A2 (fr) Procede de vaccination contre la myxomatose
ZA814154B (en) Dubstituted benzoyl-(thio)ureas,processes for their preparation and their use as agents for combating pests
ES466758A1 (es) Un procedimiento de preparacion de un virus sincitial respi-ratorio atenuado.
ZA816417B (en) Pharmaceutical composition,especially for treating infectious diseases of the respiratory tract
LU79503A1 (fr) Procede de preparation d'un vaccin syncytial du virus respiratoire
BE876164A (fr) Medicament contre des maladies infectieuses des voies respiratoires
DE3279264D1 (en) Method of immunizing pigs against aujeszky's disease
ZA796944B (en) Vaccines against diseases,caused by reovirus,and process for the preparation of those vaccines
JPS5338617A (en) Preparation of hepatitis-b vaccine
IT1237341B (it) Trattamento dei disturbi allergici
Kapral et al. Experimental staphylococcal lung infection.
GB1177206A (en) Lung Antiviral Factor
UA19158A (uk) Спосіб лікуваhhя вірусhих респіраторhих іhфекцій
GB2159820B (en) N'-(methoxy (methylthio) phosphiny)-n,n-dimethyl carbamimidothioic acid, ethyl ester
BG29955A1 (en) Concentrated inactivated oleose vaccine against virus respiratory deseases of the caitle and method for its obtaining
AU413747B2 (en) A process for concentrating and purifying influenza virus from culture media, and the preparation of a respiratory virus vaccine therefrom